Relief Therapeutics Holding AG (RLFTF)

[TurdBlossom]

According to the Investor Relations FAQ section on Relief’s own website:

“When do you expect FDA- approvals for either the intravenous or inhaled formulations?

We cannot speculate on the likelihood or timing of FDA approvals. Day 28 top-line results from the U.S. Phase 2b/3 trial with the IV formulation of RLF-100™ were announced in February 2021. We anticipate longer term day 60 data to follow in March...”

https://relieftherapeutics.com/investor-relations#